Global burden of hypertension: analysis of worldwide data
- PMID: 15652604
- DOI: 10.1016/S0140-6736(05)17741-1
Global burden of hypertension: analysis of worldwide data
Abstract
Background: Reliable information about the prevalence of hypertension in different world regions is essential to the development of national and international health policies for prevention and control of this condition. We aimed to pool data from different regions of the world to estimate the overall prevalence and absolute burden of hypertension in 2000, and to estimate the global burden in 2025.
Methods: We searched the published literature from Jan 1, 1980, to Dec 31, 2002, using MEDLINE, supplemented by a manual search of bibliographies of retrieved articles. We included studies that reported sex-specific and age-specific prevalence of hypertension in representative population samples. All data were obtained independently by two investigators with a standardised protocol and data-collection form.
Results: Overall, 26.4% (95% CI 26.0-26.8%) of the adult population in 2000 had hypertension (26.6% of men [26.0-27.2%] and 26.1% of women [25.5-26.6%]), and 29.2% (28.8-29.7%) were projected to have this condition by 2025 (29.0% of men [28.6-29.4%] and 29.5% of women [29.1-29.9%]). The estimated total number of adults with hypertension in 2000 was 972 million (957-987 million); 333 million (329-336 million) in economically developed countries and 639 million (625-654 million) in economically developing countries. The number of adults with hypertension in 2025 was predicted to increase by about 60% to a total of 1.56 billion (1.54-1.58 billion).
Interpretation: Hypertension is an important public-health challenge worldwide. Prevention, detection, treatment, and control of this condition should receive high priority.
Comment in
-
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants.Lancet. 2017 Jan 7;389(10064):37-55. doi: 10.1016/S0140-6736(16)31919-5. Epub 2016 Nov 16. Lancet. 2017. PMID: 27863813 Free PMC article.
Similar articles
-
A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010.Kidney Int. 2015 Nov;88(5):950-7. doi: 10.1038/ki.2015.230. Epub 2015 Jul 29. Kidney Int. 2015. PMID: 26221752 Free PMC article. Review.
-
Global burden of obesity in 2005 and projections to 2030.Int J Obes (Lond). 2008 Sep;32(9):1431-7. doi: 10.1038/ijo.2008.102. Epub 2008 Jul 8. Int J Obes (Lond). 2008. PMID: 18607383 Review.
-
Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries.Circulation. 2016 Aug 9;134(6):441-50. doi: 10.1161/CIRCULATIONAHA.115.018912. Circulation. 2016. PMID: 27502908 Free PMC article.
-
Current and projected prevalence of arterial hypertension in sub-Saharan Africa by sex, age and habitat: an estimate from population studies.J Hypertens. 2011 Jul;29(7):1243-52. doi: 10.1097/HJH.0b013e328346995d. J Hypertens. 2011. PMID: 21540748
-
Worldwide prevalence of hypertension: a systematic review.J Hypertens. 2004 Jan;22(1):11-9. doi: 10.1097/00004872-200401000-00003. J Hypertens. 2004. PMID: 15106785 Review.
Cited by
-
Association between air pollution and hypertension hospitalizations: a time series analysis in Lanzhou.BMC Public Health. 2024 Nov 23;24(1):3260. doi: 10.1186/s12889-024-20740-1. BMC Public Health. 2024. PMID: 39580430 Free PMC article.
-
The association between blood vitamin E and blood pressure in an adult population with and without diabetes mellitus.Front Endocrinol (Lausanne). 2024 Nov 6;15:1431293. doi: 10.3389/fendo.2024.1431293. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39568819 Free PMC article.
-
Prevalence of Hypertension and Its Clinical and Psychological Factors in Type 2 Diabetes Patients in Ghana: A Secondary Analysis of a Cross-Sectional Study.J Diabetes Res. 2024 Nov 13;2024:9286774. doi: 10.1155/2024/9286774. eCollection 2024. J Diabetes Res. 2024. PMID: 39568570 Free PMC article.
-
Preventing troublesome variability in clinical blood pressure measurement.J Hum Hypertens. 2024 Nov 20. doi: 10.1038/s41371-024-00978-3. Online ahead of print. J Hum Hypertens. 2024. PMID: 39567726
-
Triple Therapy with Telmisartan, Amlodipine, and Rosuvastatin (TAR) Versus Telmisartan/Amlodipine (TA) and Telmisartan/Rosuvastatin (TR) Combinations in Hypertension and Dyslipidemia: A Systematic Review and Meta-analysis.High Blood Press Cardiovasc Prev. 2024 Nov 19. doi: 10.1007/s40292-024-00689-3. Online ahead of print. High Blood Press Cardiovasc Prev. 2024. PMID: 39557773 Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials